- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Allison F. Kassir
Insights 51 results
Client Alert
March 12, 2024
A Brief Overview of the Federal Rulemaking Process in the United States
Newsletter
October 2, 2023
Health Headlines – October 2, 2023
Client Alert
May 10, 2023
Gas Stove Ban Update: Ninth Circuit Says "No" to City of Berkeley Ban on Gas Stoves
Client Alert
March 2, 2023
The Gathering Storm Over Gas Stoves
Client Alert
February 13, 2023
U.S. International Trade Commission to Investigate Potential Waiver of International Intellectual Property Rights for COVID-19 Diagnostics and Therapeutics
Client Alert
January 9, 2023
Not Quite the Titanic: The Food and Drug Omnibus Reform Act Rescues Some FDA Policy Initiatives
Client Alert
August 10, 2022
The Inflation Reduction Act Clears the Senate
Client Alert
June 1, 2022
Act II: The Senate Unveils Its Draft
Client Alert
May 10, 2022
And So It Begins: House Energy and Commerce Leaders Unveil FDA User Fees Legislative Package
Newsletter
December 13, 2021
Health Headlines – December 13, 2021
Client Alert
December 17, 2018
What Next for the ACA after Texas v. U.S.? What the Industry Needs to Know While the Case Is on Appeal
Newsletter
December 19, 2017
Health Headlines – December 18, 2017